FDA Resumes Posting Regulatory Science Policy Memos on Premarket Review Process Newly released memos focus on toxicology and chemistry related considerations.

https://www.fda.gov/tobacco-products/ctp-newsroom/fda-resumes-posting-regulatory-science-policy-memos-premarket-review-process?utm_campaign=ctp-pmta&utm_content=CTPStatement&utm_medium=email&utm_source=govdelivery&utm_term=stratcomms “We’ve heard loud and clear from stakeholders that opportunities exist to enhance the Center’s transparency,” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “Consistent with our commitment to do so, FDA is making previously internal memos available to the public to provide further clarity on the premarket review process. We intend to continue posting batches of memos like these on a rolling basis, as appropriate, moving forward."